Arcus Biosciences Inc (NYSE:RCUS)

$ 15.27 -0.56 (-3.54%) Market Cap: 1.40 Bil Enterprise Value: 417.63 Mil PE Ratio: 0 PB Ratio: 2.47 GF Score: 79/100

Q3 2024 Arcus Biosciences Inc Earnings Call Transcript
Nov 06, 2024

$15.73 (+2.88%)

Earnings
Q2 2024 Arcus Biosciences Inc Earnings Call Transcript
Aug 08, 2024

$13.69 (-2.21%)

Earnings
Q1 2024 Arcus Biosciences Inc Earnings Call Transcript
May 08, 2024

$15.26 (-1.93%)

Earnings
Q4 2023 Arcus Biosciences Inc Earnings Call Transcript
Feb 21, 2024

$16.41 (-1.14%)

Earnings
Q3 2023 Arcus Biosciences Inc Earnings Call Transcript
Nov 07, 2023

$16.45 (+5.65%)

Earnings
Arcus Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Arcus Biosciences Inc at Citi BioPharma Conference Transcript
Sep 06, 2023
Arcus Biosciences Inc at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023
Arcus Biosciences Inc at Barclays Global Healthcare Conference Transcript
Mar 14, 2023
Arcus Biosciences Inc at Citi Virtual Oncology Leadership Summit Transcript
Feb 21, 2023
Gilead Sciences Inc and Arcus Biosciences Inc Post ARC-7 Plenary Q&A Transcript
Dec 20, 2022
Arcus Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2022
Arcus Biosciences Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 16, 2022
Arcus Biosciences Inc at Barclays Global Healthcare Conference Transcript
Mar 17, 2022
Arcus Biosciences to Discuss the Expanded Partnership with Gilead Sciences Inc- Conference Call Transcript
Nov 18, 2021
Arcus Biosciences Inc at Citi BioPharma Conference (Virtual) Transcript
Sep 10, 2021
Q2 2021 Arcus Biosciences Inc Earnings Call Transcript
Aug 05, 2021

$30.48 (+3.67%)

Earnings
Arcus Biosciences Inc Domvanalimab Program Update Transcript
Jun 23, 2021
Arcus Biosciences Inc Annual Shareholders Meeting Transcript
Jun 03, 2021
Arcus Biosciences Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 10, 2021
Arcus Biosciences Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 02, 2021
Arcus Biosciences Inc at Evercore ISI HealthCONx Conference Transcript
Dec 02, 2020
Arcus Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 18, 2020
Arcus Biosciences Inc at Citi BioPharma Conference (Virtual) Transcript
Sep 09, 2020
Arcus Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2020
Arcus Biosciences Inc Corporate Update Transcript
May 27, 2020

Arcus Biosciences Inc at Citi Virtual Oncology Leadership Summit Transcript

Feb 21, 2023 / 06:00PM GMT

Release Date Price: $18.58 (-8.52%)

Transcript 10-K8-K

Yigal Dov Nochomovitz

Citigroup Inc. Exchange Research - Research Analyst

Okay. Great. Welcome, everyone. I'm Yigal Nochomovitz, one of the biotech analysts here at Citi. Welcome back to the Citi Oncology Summit in the first quarter of the year. So it's my pleasure to have with me senior management from Arcus, Terry Rosen, the CEO; and Juan Jaen, President. So gentlemen, welcome. Thank you so much for taking a few minutes to chat. Really appreciate it.

Terry J. Rosen

Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO

Thanks Yigal.

Yigal Dov Nochomovitz

Citigroup Inc. Exchange Research - Research Analyst

Sure. I think everyone is obviously super familiar with you guys given the debate in the TIGIT space. But nonetheless, it would be helpful if you could -- Terry, if you could just kind of level set kind of give us the quick overview of the pipeline and what are the key upcoming catalysts that people need to be aware of and just at a high level, how you -- how Arcus approaches drug development differently

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.